Clinical trial Recruiting at 1 site Interventional Ages 21 to 65

Shoulder pain relief after rotator cuff surgery using nerve blocks

Official title: Shoulder Anterior Capsular Block Versus Combined Suprascapular and Axillary Nerve Blocks for Postoperative Analgesia in Arthroscopic Rotator Cuff Repair Surgery

Run by Zagazig University · NCT06969625 · Data updated 2026-11-12

This study is testing a new way to manage pain after rotator cuff surgery using specific nerve blocks to see if it helps patients feel better with fewer side effects.

Quick facts

Study typeInterventional
Ages21 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorZagazig University
Government
Locations1 site (Zagazig, Al Sharqia)
StatusRecruiting
StartedJune 1, 2025
Main results expectedJanuary 1, 2026
Study endsJanuary 30, 2026
Registry record updatedMay 14, 2025
Trial IDNCT06969625 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 21-60 who are undergoing arthroscopic rotator cuff repair surgery and have a physical status classified as ASA 1 or II.

Probably not a fit

Patients with contraindications to regional blocks, chronic opioid use, or significant comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of a shoulder anterior capsular block (SHAC) combined with suprascapular and axillary nerve blocks (SSNB-ANB) for managing postoperative pain in patients undergoing arthroscopic rotator cuff repair surgery. The study aims to provide effective analgesia while minimizing complications associated with traditional interscalene nerve blocks. By utilizing ultrasound guidance, the trial seeks to validate the SHAC block's efficacy in improving patient outcomes and satisfaction following surgery. The approach focuses on targeting the specific nerves that innervate the shoulder joint to enhance pain management.

Why it matters

Potential benefit: If successful, this approach could significantly improve postoperative pain management and recovery for patients undergoing shoulder surgery.

How similar studies have gone: Previous studies have shown success with similar nerve block techniques, indicating potential for effective pain relief in shoulder surgeries.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients acceptance
* Age: 21-60 years
* Sex: both sexes (males or females).
* Physical status: ASA 1\& II.
* Body mass index (BMI) ≤ 30 kg/m2
* Type of operation: arthroscopic rotator cuff repair surgery.
* Duration of surgery: within 2 hours.

Exclusion Criteria:

* Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site)
* Patients with known history of allergy to the study drugs.
* patients with neuropathy involving the limb undergoing surgery
* Advanced hepatic, renal, cardiovascular, and neurologic diseases.
* history of previous shoulder operation or fracture.
* conversion to open surgery from arthroscopy.
* pregnant females
* patients with chronic opioid use

Where it's running

  • Zagazig University Hospitals
    Zagazig, Al Sharqia, Egypt
    Recruiting

Study contacts

  • Principal investigator: Sherif M. S. Mowafy, MD — Anaesthesia, Intensive Care, and Pain Management Department. Faculty of Medicine, Zagazig University
  • Study coordinator: Sherif M. S. Mowafy, MD
  • Email: sherifmowafy2012@gmail.com
  • Phone: +201003523374

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.